Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Late adverse reactions associated with the combined therapy of valproate and lamotrigine are infrequently documented within the Chinese population.

Case Presentation: This case report describes a 54-year-old female patient who developed adverse reactions following long-term therapy with valproate and lamotrigine, with symptoms emerging five months after the final adjustment of her antiseizure regimen. The patient presented with symptoms of dizziness, ataxia, nystagmus, and postural tremors. Following blood drug concentration monitoring and subsequent minor dosage adjustments to the antiseizure regimen without medication withdrawal, the patient's symptoms were successfully resolved.

Conclusions: This article underscores the importance of vigilance among clinicians regarding the potential for late adverse reactions and advocates for the proactive monitoring of blood drug concentrations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042444PMC
http://dx.doi.org/10.1186/s42494-025-00217-3DOI Listing

Publication Analysis

Top Keywords

adverse reactions
16
late adverse
12
therapy valproate
12
case report
8
valproate lamotrigine
8
antiseizure regimen
8
blood drug
8
report late
4
adverse
4
reactions
4

Similar Publications

Adhesive materials are widely used in microvascular decompression for treating neurovascular compression syndromes. They play an important role in the critical step of vessel fixation. Recently, completely autologous fibrin glue produced solely from a patient's own plasma was developed.

View Article and Find Full Text PDF

[Effect of Kamishoyosan on Primary Dysmenorrhea Pain].

Yakugaku Zasshi

September 2025

Kampo Research Laboratories, Pharmaceutical Company, Kracie, Ltd.

Dysmenorrhea refers to pathological symptoms that occur in association with menstruation during the menstrual period. Treatment options for dysmenorrhea include nonsteroidal anti-inflammatory drugs (NSAIDs) and low-dose estrogen-progestin combination pills. However, some patients do not respond to these treatments, and long-term use can lead to adverse reactions, raising additional problems.

View Article and Find Full Text PDF

Modelling allopurinol-induced severe adverse cutaneous reactions.

Lancet Rheumatol

September 2025

University of Otago Christchurch, Christchurch, New Zealand; Christchurch Hospital, Health New Zealand Waitaha, Christchurch, New Zealand.

View Article and Find Full Text PDF

Background: Allopurinol, the most prescribed urate-lowering drug, is a known cause of severe cutaneous adverse reactions. We aimed to develop and validate a model to assess the risk of allopurinol-induced severe cutaneous adverse reactions in adults newly prescribed allopurinol.

Methods: In this retrospective new-user cohort study, we developed and validated a prognostic model using primary care, hospitalisation, and mortality data extracted from the UK Clinical Practice Research Datalink (CPRD) primary care database, for the period Jan 1, 2001, to March 29, 2021.

View Article and Find Full Text PDF

Aim: This study evaluates the efficacy and safety of scalp acupuncture in treating tic disorders.

Methods: We conducted a meta-analysis using data from 19 randomized controlled trials (RCTs) involving 1463 patients, sourced from various databases up to May 16, 2023. Stata15.

View Article and Find Full Text PDF